Concepedia

Author

Xinying Su

Shanghai Jiao Tong University

Also Known As

Xin-Ying Su, XinYing Su, Xinying Su

80

Publications

2.2K

Citations

21

H-Index

39

Concepts

All Affiliations

Shanghai Jiao Tong UniversityShanghai Innovative Research Center of Traditional Chinese MedicineAstraZeneca (United Kingdom)Renji HospitalShanghai Chest Hospital
XS

About

Xinying Su is an author at Shanghai Jiao Tong University specializing in medicine, molecular diagnostics, and pathology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

9

9

438

2

Cell Biology

5

5

353

3

Engineering

4

4

340

4

Health Sciences

2

2

45

5

Chemical Engineering

1

1

33

Xinying Su

×

26

Publications

2.1K

Citations

21

H-Index

YearCitations

Studies on Treatment of Acute Promyelocytic Leukemia With Arsenic Trioxide: Remission Induction, Follow-Up, and Molecular Monitoring in 11 Newly Diagnosed and 47 Relapsed Acute Promyelocytic Leukemia Patients

Chao Niu, Hua Yan, Ting Yu,

Blood

1999

626

Genomic Landscape Survey Identifies SRSF1 as a Key Oncodriver in Small Cell Lung Cancer

Liyan Jiang, Jiaqi Huang, Brandon W. Higgs,

PLoS Genetics

2016

265

<i>FGFR2</i> Gene Amplification in Gastric Cancer Predicts Sensitivity to the Selective FGFR Inhibitor AZD4547

Liang Xie, Xinying Su, Lin Zhang,

Clinical Cancer Research

2013

236

Translating the Therapeutic Potential of AZD4547 in <i>FGFR1</i> -Amplified Non–Small Cell Lung Cancer through the Use of Patient-Derived Tumor Xenograft Models

Jingchuan Zhang, Lin Zhang, Xinying Su,

Clinical Cancer Research

2012

155

Volitinib, a potent and highly selective c‐Met inhibitor, effectively blocks c‐Met signaling and growth in c‐MET amplified gastric cancer patient‐derived tumor xenograft models

Paul R. Gavine, Yongxin Ren, Lu Han,

Molecular Oncology

2014

118

Establishment of patient-derived non-small cell lung cancer xenograft models with genetic aberrations within EGFR, KRAS and FGFR1: useful tools for preclinical studies of targeted therapies

Xu‐Chao Zhang, Jingchuan Zhang, Ming Li,

Journal of Translational Medicine

2013

86

Whole genome gene copy number profiling of gastric cancer identifies <i>PAK1</i> and <i>KRAS</i> gene amplification as therapy targets

Ziliang Qian, Guanshan Zhu, Lili Tang,

Genes Chromosomes and Cancer

2014

73

PD-L1 expression and its relationship with oncogenic drivers in non-small cell lung cancer (NSCLC)

Liyan Jiang, Xinying Su, Tianwei Zhang,

Oncotarget

2017

62

A retrospective analysis of RET translocation, gene copy number gain and expression in NSCLC patients treated with vandetanib in four randomized Phase III studies

Adam Platt, John Morten, Qunsheng Ji,

BMC Cancer

2015

58

Trastuzumab anti-tumor efficacy in patient-derived esophageal squamous cell carcinoma xenograft (PDECX) mouse models

Xian-hua Wu, Jingchuan Zhang, Ruheng Zhen,

Journal of Translational Medicine

2012

45

Page 1